OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 11
Showing 11 citing articles:
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency
Yanli Song, Jiaolei Wang, Zhihui Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Yanli Song, Jiaolei Wang, Zhihui Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 3
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 3
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk
D Chen, Weihong Zhang, Bin Xiao, et al.
Journal of Virology (2024)
Open Access | Times Cited: 1
D Chen, Weihong Zhang, Bin Xiao, et al.
Journal of Virology (2024)
Open Access | Times Cited: 1
COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases
José M. Serra López-Matencio, Esther F. Vicente‐Rabaneda, Estefanía Alañón, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1813-1813
Open Access | Times Cited: 3
José M. Serra López-Matencio, Esther F. Vicente‐Rabaneda, Estefanía Alañón, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1813-1813
Open Access | Times Cited: 3
Epidemiology, risk factors, and vaccine effectiveness for SARS-CoV-2 infection among healthcare workers during the omicron pandemic in Shanghai, China
D Wang, Dan Zhu, Min Xia, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32182-e32182
Open Access
D Wang, Dan Zhu, Min Xia, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32182-e32182
Open Access
EFICACIA Y SEGURIDAD DE LAS VACUNAS COVID-19
GABRIEL RADA G.
Boletín : (2024), Iss. LX, pp. 165-175
Open Access
GABRIEL RADA G.
Boletín : (2024), Iss. LX, pp. 165-175
Open Access
Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”
Amin Sharifan
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Amin Sharifan
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Antibody response to SARS-CoV-2 natural and breakthrough infection in patients undergoing maintenance hemodialysis: a prospective cohort study over 4 months
Y. Chen, Xiaming Zhang, Mi Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38545-e38545
Open Access
Y. Chen, Xiaming Zhang, Mi Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38545-e38545
Open Access
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
